Cleanroom Industry News Articles

Northvolt to Build €4 Billion Battery Gigafactory in Northern Germany

The Swedish electric vehicle battery manufacturer says it will construct a major new production facility in the city of Heide near Germany’s North Sea coastline.

Celerion Expands Early Phase Clinical Pharmacology Units

Celerion, a clinical research organization (CRO) to the biopharmaceutical industry, has announced completion of additions to its research capacity and services

CARsgen Therapeutics launches 37,000-ft cleanroom facility for clinical and early-stage commercial manufacturing

CARsgen Therapeutics 37,000-ft facility for clinical and early-stage commercial manufacturing was designed and built in just 12 months.

On Demand Pharmaceuticals Commissions State-of-the-Art, cGMP Medicine Manufacturing Facility

The CGMP facility represents a critical first step in a new era of drug manufacturing aimed at strengthening domestic supply chain resiliency

Zeus Invests in Global Expansion to Increase Catheter Manufacturing Capacity

Zeus Invests in Global Expansion to Increase Catheter Manufacturing Capacity

Zeus, the global leader in advanced polymer solutions, today announced a multi-million dollar investment to expand its catheter manufacturing capacity worldwide

SK pharmteco Announces $35m Investment in Phase 1 of New Pharmaceutical Manufacturing Plant

SK pharmteco Announces $35m Investment in Phase 1 of New Pharmaceutical Manufacturing Plant

SK pharmteco, is pleased to announce $35m investment for the initial phase of an expansion plan for SK biotek Ireland’s Dublin-based pharmaceutical manufacturing plant.

Pfizer to invest $120M at Kalamazoo facility for COVID-19 antiviral treatment

Pfizer to invest $120M at Kalamazoo facility for COVID-19 antiviral treatment

Pfizer Inc. has planned a $120 million investment at its Kalamazoo manufacturing facility to support the production of its COVID-19 antiviral treatment, Paxlovid.

Signature Biologics™ Opens Expanded Manufacturing and R&D Headquarters in Irving, TX

Signature Biologics™ Opens Expanded Manufacturing and R&D Headquarters in Irving, TX

Signature Biologics, LLC., today announced their expanded operations footprint to include a new 36,000 sq ft facility in Irving, TX. This newly constructed space mirrors Signature Biologics’ transparency in doing business with open floor plan and floor-to-ceiling views into its fully equipped manufacturing and R&D laboratory spaces.

read more
NGen & Evercloak Collaborate to Scale Innovative Graphene-Based Membrane Manufacturing

NGen & Evercloak Collaborate to Scale Innovative Graphene-Based Membrane Manufacturing

Next Generation Manufacturing Canada, the industry-led organization behind Canada’s Advanced Manufacturing Supercluster, has announced over $4.5 million in collaborative investment to scale up commercial applications of graphene nanofilms in HVAC systems for cleanrooms and other critical environment systems.

read more
First Solar breaks ground on 3.3 GW production facility

First Solar breaks ground on 3.3 GW production facility

The new 3.3 gigawatt (GW)DC facility, which is scheduled to commence operations in the first half of 2023, represents a $680 million investment. When fully operational, the facility is expected to scale the company’s Northwest Ohio footprint to a total annual capacity of 6 GWDC, which is believed to make it the largest fully vertically integrated solar manufacturing complex outside China.

read more
Exyte developed Factory Concept for Morrow Batteries’ leading edge and sustainable Li-ion Battery Giga-Site in Norway

Exyte developed Factory Concept for Morrow Batteries’ leading edge and sustainable Li-ion Battery Giga-Site in Norway

Exyte, a global leader in the design, engineering, and delivery of facilities for high-tech industries, has collaborated with Morrow Batteries (“Morrow”) in the development of integrated production concepts for their new state-of-the-art Lithium-Ion battery production site in Norway.

read more
Artiva Biotherapeutics Builds New US Cell Therapy R&D and Manufacturing Facility

Artiva Biotherapeutics Builds New US Cell Therapy R&D and Manufacturing Facility

Artiva Biotherapeutics, an oncology company specializing in primary allogeneic natural killer (NK) cell therapies to treat cancer, announced on Aug. 12, 2021 an expansion of its US presence with a new R&D and GMP manufacturing facility in San Diego, Calif., for cell therapies.

read more
Rentschler Biopharma lays the foundation stone for a new US production facility in the greater Boston area

Rentschler Biopharma lays the foundation stone for a new US production facility in the greater Boston area

New facility at the existing facility in Milford, MA, USA will significantly expand cGMP manufacturing capabilities and accelerate the clinical and commercial supply of vital biopharmaceuticals

read more